Stephen J Halliday MD MSCI
Critical Care Medicine, Interstitial Lung Diseases
Assistant Professor of Medicine
Join to View Full Profile
600 Highland AveMadison, WI 53792
Phone+1 608-263-7203
Dr. Halliday is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am a pulmonary and critical care physician with an interest in interstitial lung disease, critical care, bronchoscopy and other pulmonary procedures, and medical education. I completed my residency, chief residency, and fellowship at Vanderbilt, and now practice at University of Wisconsin Hospitals and Clinics, and the William S. Middleton VA Hospital.
Education & Training
Vanderbilt UniversityMSCI, 2017 - 2019
Vanderbilt University Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 2015 - 2019- Vanderbilt University Medical CenterChief Residency, Internal Medicine, 2014 - 2015
- Vanderbilt University Medical CenterResidency, Internal Medicine, 2011 - 2014
The University of Texas Health Science Center at San AntonioClass of 2011, M.D.- Davidson CollegeBS, Biology, 2003 - 2007
Certifications & Licensure
IL State Medical License 2019 - 2026
WI State Medical License 2019 - 2025
TN State Medical License 2013 - 2021
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Distinction in Leadership Training Vanderbilt University Medical Center, 2015
- Inductee Alpha Omega Alpha Honor Medical Society, 2011
Clinical Trials
- A Clinical Study to Test How Effective and Safe GLPG1690 is for Participants With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care Start of enrollment: 2018 Nov 05
- A Study to Evaluate the Efficacy and Safety of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis Start of enrollment: 2021 Mar 19
- Zephyrus II: Efficacy and Safety Study of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) Start of enrollment: 2020 Sep 30
- Join now to see all
Publications & Presentations
PubMed
- Diabetes Mellitus Is Not a Risk Factor for Difficult Intubation Among Critically Ill Adults: A Secondary Analysis of Multicenter Trials.Micah T Long, Bryan M Krause, Audrey de Jong, John T Dollerschell, J Michael Brewer
Critical Care Medicine. 2025-01-01 - Association Between Neuromuscular Blocking Agents and Outcomes of Emergency Tracheal Intubation: A Secondary Analysis of Randomized Trials.Stephanie C DeMasi, Wesley H Self, Neil R Aggarawal, Michael D April, Luke Andrea
Annals of Emergency Medicine. 2025-01-01 - 14 citationsNoninvasive Ventilation for Preoxygenation during Emergency Intubation.Kevin W Gibbs, Matthew W Semler, Brian E Driver, Kevin P Seitz, Susan B Stempek
The New England Journal of Medicine. 2024-06-20
Press Mentions
Researchers at Vanderbilt Publish First Study from PHA’s 2018 Research RoomNovember 29th, 2018
Grant Support
- Clinical and Translational Research Training Program in Pulmonary MedicineNIH2017–2019
Professional Memberships
- Member
- Member
- Pulmonary Hypertension AssociationMember
- Member
External Links
- UW Sitehttps://www.uwhealth.org/findadoctor/profile/stephen-j-halliday-md/11168
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
